Cytokinetics (CYTK)
(Delayed Data from NSDQ)
$71.41 USD
+0.26 (0.37%)
Updated Mar 27, 2024 04:00 PM ET
After-Market: $72.21 +0.80 (1.12%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-1.16 | 0.00% |
Earnings Summary
For their last quarter, Cytokinetics (CYTK) reported earnings of -$1.38 per share, missing the Zacks Consensus Estimate of -$1.03 per share. This reflects a negative earnings surprise of 33.98%. Look out for CYTK's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$1.16 per share, reflecting a year-over-year increase of 15.94%.
Earnings History
Price & Consensus
Zacks News for CYTK
Tarsus Pharmaceuticals, Inc. (TARS) Moves 8.5% Higher: Will This Strength Last?
CYTK: What are Zacks experts saying now?
Zacks Private Portfolio Services